Oncolys BioPharma Inc. | Balance Sheet
Fiscal year is January-December. All values JPY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,580
4,727
3,605
2,564
2,868
2,463
Total Accounts Receivable
15
60
24
97
122
110
Inventories
22
19
16
15
19
11
Other Current Assets
15
78
29
70
64
34
Total Current Assets
5,631
4,885
3,674
2,747
3,072
2,618
Net Property, Plant & Equipment
36
59
46
-
3
2
Total Investments and Advances
28
62
280
392
451
781
Intangible Assets
1
1
4
-
-
-
Other Assets
-
2
2
2
1
29
Total Assets
5,697
5,009
4,006
3,140
3,526
3,430
ST Debt & Current Portion LT Debt
160
183
104
73
103
Income Tax Payable
18
12
10
25
33
Other Current Liabilities
55
68
63
107
103
Total Current Liabilities
233
263
177
205
239
Long-Term Debt
359
366
325
315
352
Provision for Risks & Charges
2
3
3
3
4
Other Liabilities
6
-
-
-
-
Total Liabilities
603
637
504
523
594
Common Equity (Total)
5,094
4,371
3,501
2,617
2,932
Total Shareholders' Equity
5,094
4,371
3,501
2,617
2,932
Total Equity
5,094
4,371
3,501
2,617
2,932
Liabilities & Shareholders' Equity
5,697
5,009
4,006
3,140
3,526
About Oncolys BioPharma
View Profile
